Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Congenital Hyperinsulinism International



Address

P.O. Box 135
Glen Ridge, NJ 07028

Phone

9735448372

Email Address

[email protected]

Description

The Congenital Hyperinsulinism International (CHI) is a voluntary, non-profit organization dedicated to improving the lives of children, adults, and families living with congenital hyperinsulinism. Congenital hyperinsulinism, also referred to as persistent hyperinsulinemic hypoglycemia of infancy (PHHI), is the most common cause of persistent hypoglycemia in infancy. It is due to defective negative feedback regulation of insulin secretion by low glucose levels. Early recognition, diagnosis, and treatment are necessary to prevent or minimize neurologic damage from recurrent or prolonged episodes of hypoglycemia.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.